S. Ebbinghaus - Concepedia

Author

S. Ebbinghaus

Also Known As

S. Ebbinghaus, Scott Ebbinghaus, Svante Ebbinghaus

Publications

283

Citations

H-Index

Concepts

All Affiliations

S. Ebbinghaus is an author at University of Colorado Cancer Center specializing in molecular pharmacology, oncology, and cancer therapeutics.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	54
2	Pharmacology	2	2	54
3	Cell Biology	1	1	21
4	Molecular Medicine	1	1	33
5	Pathology	1	1	33

S. Ebbinghaus

Publications

261

Citations

H-Index

Page 1

	Year	Citations
Characterization of a Novel Prostate-Specific Antigen–Activated Peptide-Doxorubicin Conjugate in Patients With Prostate Cancer Robert S. DiPaola, John J. Rinehart, John Nemunaitis, Journal of Clinical Oncology	2002	83
Phase Ib/II Study of Pembrolizumab and Pegylated-Interferon Alfa-2b in Advanced Melanoma Diwakar Davar, Hong Wang, Joe-Marc Chauvin, Journal of Clinical Oncology	2018	79
Treatment of patients with metastatic melanoma with bryostatin-1 - phase II study R. Gonzalez, S. Ebbinghaus, T. K. Henthorn, Melanoma Research	1999	45
Apo2L/TRAIL pharmacokinetics in a phase 1a trial in advanced cancer and lymphoma Jia Ling, Roy S. Herbst, David S. Mendelson, Journal of Clinical Oncology Chemoprevention StrategyApoptosisPathologyCell DeathPharmacotherapy	2006	33
Phase II study of synthadotin (SYN-D; ILX651) administered daily for 5 consecutive days once every 3 weeks (qdx5q3w) in patients (Pts) with inoperable locally advanced or metastatic melanoma S. Ebbinghaus, E. Hersh, Casey Cunningham, Journal of Clinical Oncology Microtubule NucleationPhase Ii StudyPharmacotherapyDermatologyConsecutive Days	2004	21

Page 1